Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways

BACKGROUND: Breast cancer (BC) is one of the most common malignant tumors with the highest mortality in the world. Modern pharmacological studies have shown that Syringin has an inhibitory effect on many tumors, but its anti-BC efficacy and mechanism are still unclear. METHODS: First, Syringin was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Yuan, Chong, Liu, Bo, Yang, Yan-Fang, Wu, He-Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258109/
https://www.ncbi.nlm.nih.gov/pubmed/35794555
http://dx.doi.org/10.1186/s12967-022-03504-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258109/
https://www.ncbi.nlm.nih.gov/pubmed/35794555
http://dx.doi.org/10.1186/s12967-022-03504-6

Ejemplares similares